Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28785467 | 0.92 | GPR55 (0.48) | KDM4EMEN1ALDH1A1CYP1A2GLA | |
| SCHEMBL29913819 | 0.91 | KDM4E (0.57) | KDM4EMEN1ALDH1A1CYP1A2GLA | |
| SCHEMBL7110822 | 0.90 | GPR55 (0.48) | GPR55 | |
| SCHEMBL28227062 | 0.87 | PLA2G10 (0.46) | KDM4EMEN1ALDH1A1HPGDKMT2A | |
| SCHEMBL9517988 | 0.87 | GPR55 (0.46) | GPR55 | |
| SCHEMBL9317066 | 0.85 | SOX18 (0.51) | KDM4EMEN1ALDH1A1CYP1A2GLA | |
| SCHEMBL11598755 | 0.85 | P2RX3 (0.55) | KDM4EMEN1ALDH1A1CYP1A2GLA | |
| SCHEMBL897607 | 0.82 | KDM4E (0.55) | KDM4EMEN1ALDH1A1CYP1A2GLA | |
| SCHEMBL2507677 | 0.81 | KDM4E (0.53) | KDM4EMEN1ALDH1A1CYP1A2GLA | |
| SCHEMBL8574060 | 0.81 | KDM4E (0.53) | KDM4EMEN1ALDH1A1CYP1A2GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8647878-B2 | Highly refractive immersion liquids and their use | CARL ZEISS AG (DE) | 2014-02-11 | — | — | US | disclosed |
| US-20100212547-A1 | Highly Refractive Immersion Liquids And Their Use | CARL ZEISS AG (DE) | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100212547-A1 | Highly Refractive Immersion Liquids And Their Use | NR4A3, NR2E3, NR4A1 | KDM4E 3365/4885MEN1 2974/4885ALDH1A1 3757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.